Evidence map›Paper›PMID 36942904›Full record

SynthesisRadiology and oncology2023

Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis.

Jelena Kostic Peric, Andja Cirkovic, Sanja Srzentic Drazilov, Natalija Samardzic, Vesna Skodric Trifunovic, Dragana Jovanovic, Sonja Pavlovic

Open access · goldAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Radiology and oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.International journal of molecular sciences · 2024
    Review
  7. Differences and similarities ofTranslational lung cancer research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jelena Kostic PericInstitute for Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Andja CirkovicDepartment for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Sanja Srzentic DrazilovInstitute for Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Natalija SamardzicUniversity Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia.
Vesna Skodric TrifunovicUniversity Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia.
Dragana JovanovicInternal Medicine Clinic "Akta Medica", Belgrade, Serbia.
Sonja PavlovicInstitute for Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
University of Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThymomas belong to rare tumors giving rise to thymic epithelial tissue. There is a classification of several forms of thymoma: A, AB, B1, B2, B3, thymic carcinoma (TC) and thymic neuroendocrine thymoma. In this meta-analysis study, we have focused on thymoma using articles based on the disease's next-generation sequencing (NGS) genomic profiling. MATERIALS AND

methodsWe conducted a systematic review and meta-analysis of the prevalence of studies that discovered the genes and variants occurring in the less aggressive forms of the thymic epithelial tumors. Studies published before 12

resultsFinally, 12 publications were included in the qualitative as well as quantitative analysis. The three genes,

conclusionsAccording to obtained data, we noticed that the

Indexed as

Neoplasms, Glandular and EpithelialThymomaThymus NeoplasmsTranscription Factors, TFIIIHigh-Throughput Nucleotide SequencingHumansTranscription Factors, TFIIImeta-analysisnext-generation sequencing (NGS)SNVs/InDelsthymoma

Identifiers

PMID36942904
PMCPMC10039471
OpenAlexW4328047965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.